Adam Frampton

Biography

Adam is currently an Honorary Clinical Lecturer working in the Department of Surgery & Cancer at Hammersmith Hospital, Imperial College London. He is also a London Deanery (South-West Thames) General & HPB Surgical Registrar. Adam undertook his undergraduate medical training at Charing Cross Hospital (ICSM) from 1997-2003 and achieved a First Class intercalated BSc(Hons) in Pharmacology and Toxicology at Imperial College. He completed his Basic Surgical Training in Surrey and then spent a year doing Renal Transplant and Vascular Access Surgery at St. Georges Hospital, Tooting. At the same time he completed a MSc with Merit in Surgical Practice. He joined the HPB Surgical Unit at the Hammersmith Hospital in 2009 as a Clinical Research Fellow to develop the TVoSS (True Value of Surgical Services) clinical coding project and undertake a period of basic science and translational research. He was awarded his PhD in Molecular Oncology in 2014, working under the supervision of Dr Leandro Castellano, Professor Justin Stebbing and Professor Long Jiao. Adam now runs a lab group with Dr Jonathan Krell investigating Molecular Oncogenetics. His research aims are to discover crucial microRNAs involved in the development and progression of Pancreatic Ductal Adenocarcinoma (PDAC), as well as elucidating their mechanistic roles. He is also investigating the role of microRNAs as biomarkers for improving pre-operative diagnosis and stratification, and also as possible targets for therapy. He won the Moynihan Prize in May 2017 for his research, which is the most prestigious scientific award given by the Association of Surgeons of Great Britain & Ireland (ASGBI). Adam was elected as a Fellow of the Royal Society of Biology (FRSB) in July 2017 for his contributions to small RNA and cancer biology.

Research Interest

Surgery & Cancer